Stockreport

Early-stage study of combination of Aduro's ADU-S100 and Novartis' PDR001 underway [Seeking Alpha]

ADURO BIOTECH  (ADRO) 
Last aduro biotech earnings: 3/9 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aduro.com
PDF Early-stage study of combination of Aduro's ADU-S100 and Novartis' PDR001 underwayThe first patient has beendosed in aPhase 1b clinical trial assessing the combination o [Read more]